Susan K. Seo
About
Susan K. Seo is a scholar working on Infectious Diseases, Oncology and Epidemiology.
According to data from OpenAlex, Susan K. Seo has authored 98 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Infectious Diseases, 41 papers in Oncology and 40 papers in Epidemiology. Recurrent topics in Susan K. Seo's work include Neutropenia and Cancer Infections (24 papers), Antifungal resistance and susceptibility (18 papers) and Bacterial Identification and Susceptibility Testing (15 papers). Susan K. Seo is often cited by papers focused on Neutropenia and Cancer Infections (24 papers), Antifungal resistance and susceptibility (18 papers) and Bacterial Identification and Susceptibility Testing (15 papers). Susan K. Seo collaborates with scholars based in United States, Italy and Spain. Susan K. Seo's co-authors include Donald W. Landry, Juan Oliver, David A. D’Alessandro, Howard R. Levin, Joshua A. Hill, Mehmet C. Öz, Nina Cohen, Ying Taur, Robert C. Ashton and Genovefa A. Papanicolaou and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Blood.
In The Last Decade
Susan K. Seo
90 papers receiving 3.6k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Susan K. Seo United States | 29 | 1.6k | 1.0k | 932 | 550 | 459 | 98 | 3.6k | ||
| Jennie Johnstone Canada | 35 | 1.7k 1.1× | 553 0.5× | 934 1.0× | 629 1.1× | 384 0.8× | 140 | 4.5k | ||
| Mette Søgaard Denmark | 32 | 1.1k 0.7× | 647 0.6× | 534 0.6× | 536 1.0× | 409 0.9× | 153 | 3.8k | ||
| Su Jin Jeong South Korea | 31 | 1.4k 0.9× | 408 0.4× | 1.4k 1.5× | 396 0.7× | 635 1.4× | 258 | 4.2k | ||
| June Myung Kim South Korea | 32 | 1.2k 0.8× | 373 0.4× | 876 0.9× | 297 0.5× | 546 1.2× | 202 | 3.6k | ||
| Juan González del Castillo Spain | 28 | 1.1k 0.7× | 508 0.5× | 460 0.5× | 440 0.8× | 357 0.8× | 271 | 3.5k | ||
| Stefano Bassetti Switzerland | 36 | 1.1k 0.7× | 313 0.3× | 1.9k 2.0× | 388 0.7× | 786 1.7× | 159 | 5.6k | ||
| Brian T. Fisher United States | 34 | 1.5k 1.0× | 1.2k 1.2× | 1.3k 1.4× | 390 0.7× | 223 0.5× | 195 | 3.6k | ||
| Pierre‐Emmanuel Charles France | 29 | 1.5k 0.9× | 290 0.3× | 883 0.9× | 448 0.8× | 481 1.0× | 80 | 3.1k | ||
| Heinz Burgmann Austria | 34 | 1.5k 0.9× | 217 0.2× | 865 0.9× | 559 1.0× | 554 1.2× | 202 | 4.0k | ||
| P. Berthelot France | 36 | 1.7k 1.1× | 595 0.6× | 997 1.1× | 393 0.7× | 781 1.7× | 207 | 4.7k |
Countries citing papers authored by Susan K. Seo
Since
Specialization
Citations
This map shows the geographic impact of Susan K. Seo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan K. Seo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan K. Seo more than expected).
Fields of papers citing papers by Susan K. Seo
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Susan K. Seo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan K. Seo. The network helps show where Susan K. Seo may publish in the future.
Co-authorship network of co-authors of Susan K. Seo
This figure shows the co-authorship network connecting the top 25 collaborators of Susan K. Seo. A scholar is included among the top collaborators of Susan K. Seo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan K. Seo. Susan K. Seo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Seo, Susan K., et al.. (2025). Robotic Rectus Abdominis Myoperitoneal Flap for Posterior Vaginal Wall Reconstruction: Experience at a Single Institution. Journal of Clinical Medicine. 14(1). 292–292.
2.
Kim, Hyung‐Jun, Jae Ho Lee, Choon‐Taek Lee, et al.. (2025). Lung Microphysiological System Validates Novel Cell Therapy for Acute Respiratory Distress Syndrome. Advanced Biology. 10(1). e00225–e00225.
3.
McMillen, Tracy, et al.. (2025). Decrease in SinglePlex Viral PCRs Use and acyclovir utilization following implementation of The BioFire Meningitis/Encephalitis Panel at A Tertiary Care Cancer Center. PubMed. 5(3). 100221–100221.
4.
Su, Yiqi, Y. Li, Renee L. Gennarelli, et al.. (2024). Impact of Primary Letermovir Prophylaxis Versus Preemptive Antiviral Therapy for Cytomegalovirus on Economic and Clinical Outcomes after Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 30(8). 792.e1–792.e12.
5.
Shahid, Zainab, Tania Jain, M. Veronica Dioverti, et al.. (2024). Best Practice Considerations by The American Society of Transplant and Cellular Therapy: Infection Prevention and Management After Chimeric Antigen Receptor T Cell Therapy for Hematological Malignancies. Transplantation and Cellular Therapy. 30(10). 955–969.
6.
Melica, Giovanna, Alejandro Luna, Gunjan L. Shah, et al.. (2024). Shift from Widespread to Tailored Antifungal Prophylaxis in Lymphoma Patients Treated with CD19 CAR T Cell Therapy: Results from a Large Retrospective Cohort. Transplantation and Cellular Therapy. 31(1). 36–44.
7.
Laracy, Justin, Nina Cohen, Elizabeth Robilotti, et al.. (2023). Predictors of SARS-CoV-2 Omicron breakthrough infection after receipt of AZD7442 (tixagevimab-cilgavimab) for pre-exposure prophylaxis among hematologic malignancy patients. Haematologica. 108(11). 3058–3067.
8.
Chaer, Firas El, Daniel Kaul, Janet A. Englund, et al.. (2023). American Society of Transplantation and Cellular Therapy Series: #7 - Management of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients. Transplantation and Cellular Therapy. 29(12). 730–738.
9.
Lin, Andrew, Samantha Brown, Yeon Joo Lee, et al.. (2023). Patterns of CMV infection after letermovir withdrawal in recipients of posttransplant cyclophosphamide–based transplant. Blood Advances. 7(23). 7153–7160.
10.
Melica, Giovanna, Alejandro Luna, Magdalena Corona, et al.. (2023). From Widespread to Tailored Antifungal Prophylaxis in Lymphoma Patients Treated with CD19 CAR T- Cell Therapy: Less Is Better. Blood. 142(Supplement 1). 3514–3514.
11.
Politikos, Ioannis, Carmen Lau, Sean M. Devlin, et al.. (2022). Extended-duration letermovir prophylaxis for cytomegalovirus infection after cord blood transplantation in adults. Blood Advances. 6(24). 6291–6300.
12.
Stern, Anat, Yiqi Su, Yeon Joo Lee, et al.. (2020). A Single-Center, Open-Label Trial of Isavuconazole Prophylaxis against Invasive Fungal Infection in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 26(6). 1195–1202.
13.
Lin, Andrew, Molly Maloy, Yiqi Su, et al.. (2019). Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real‐world experience. Transplant Infectious Disease. 21(6). e13187–e13187.
14.
Hedayat, A., Travis J. Hollmann, Michael A. Marchetti, et al.. (2019). Gram‐negative cutaneous infections with unique filamentous forms. Journal of Cutaneous Pathology. 46(6). 459–462.
15.
Kobos, Rachel, et al.. (2017). Voriconazole Dosing in Children Younger Than 3 Years Undergoing Cancer Chemotherapy or Hematopoietic Stem Cell Transplantation. Journal of the Pediatric Infectious Diseases Society. 7(2). 169–171.
16.
Seo, Susan K., Kaming Lo, & Lilian M. Abbo. (2016). Current State of Antimicrobial Stewardship at Solid Organ and Hematopoietic Cell Transplant Centers in the United States. Infection Control and Hospital Epidemiology. 37(10). 1195–1200.
17.
Parameswaran, Lalitha, Ying Taur, Monika K. Shah, Tiffany A. Traina, & Susan K. Seo. (2014). Tolerability of Chemotherapy in HIV-Infected Women with Breast Cancer: Are There Prognostic Implications?. AIDS Patient Care and STDs. 28(7). 358–364.
18.
Redelman‐Sidi, Gil, et al.. (2010). Esophageal Actinomycosis in a Fifty-Three-Year-Old Man with HIV: Case Report and Review of the Literature. AIDS Patient Care and STDs. 24(2). 73–78.
19.
Cohen, Nina, David J. Chung, Susan K. Seo, et al.. (2009). Hepatic Safety of Voriconazole after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 16(1). 46–52.
20.
Seo, Susan K., et al.. (2004). A multidisciplinary approach to antimicrobial stewardship: evolution into the 21st century. International Journal of Antimicrobial Agents. 25(1). 1–10.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Jennie Johnstone Breakdown of academic impact, for papers by Mette Søgaard Breakdown of academic impact, for papers by Su Jin Jeong Breakdown of academic impact, for papers by June Myung Kim Breakdown of academic impact, for papers by Juan González del Castillo Breakdown of academic impact, for papers by Stefano Bassetti Breakdown of academic impact, for papers by Brian T. Fisher Breakdown of academic impact, for papers by Pierre‐Emmanuel Charles Breakdown of academic impact, for papers by Heinz Burgmann Breakdown of academic impact, for papers by P. Berthelot